Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions
Authors:
- François GaaschtFrançois Gaascht
- Mario DicatoMDMario Dicato
- Marc DiederichMarc Diederich
- 1 November 2013
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 86 (9) , 1239-1247
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated ProteinsJournal of Breast Cancer, 2013
- NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell deathBMC Complementary and Alternative Medicine, 2012
- Regulation of the human catalytic subunit of telomerase (hTERT)Gene, 2012
- Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90Molecular Cancer, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- European materia medica in historical texts: Longevity of a tradition and implications for future useJournal of Ethnopharmacology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoterCarcinogenesis, 2008
- Cancer immunoediting from immune surveillance to immune escapeImmunology, 2007